People

Colwell, who will become the president in 1995, is the seventh woman president-elect of AAAS, the world's largest general scientific organization. "The goals that they've [AAAS] set for themselves are goals that I fully endorse," says Colwell, referring to the organization's objectives for the future, such as developing a series of forums on science policy and future directions for science and technology. Colwell says that when sh

Written byKaren Kreeger
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

Colwell, who will become the president in 1995, is the seventh woman president-elect of AAAS, the world's largest general scientific organization.

"The goals that they've [AAAS] set for themselves are goals that I fully endorse," says Colwell, referring to the organization's objectives for the future, such as developing a series of forums on science policy and future directions for science and technology.

Colwell says that when she becomes president, one of her key roles will be to find ways to more broadly communicate to researchers, policymakers, and AAAS members some of the less well-known programs of the organization.

"Everyone thinks of Science magazine, but AAAS is active in many [other] areas," says Colwell. She cites as examples work in international collaborations, science education, and science policy.

Colwell says she also wants to promote the role that AAAS can play in shaping science-education reform and science policy for the future. "There's ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies